Cancer Research  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 3712-3715, September 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, C. J.
Right arrow Articles by Pardee, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, C. J.
Right arrow Articles by Pardee, A. B.

Induction of Apoptosis by ß-Lapachone in Human Prostate Cancer Cells1

Chiang J. Li2, Chuanlin Wang and Arthur B. Pardee

Division of Cell Growth and Regulation, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115

ß-Lapachone, a plant product, has been shown to be a novel inhibitor of DNA topoisomerase I, with a mode of action different from camptothecin and a chemical structure distinct from those of current anti-cancer drugs. We observed that ß-lapachone, at concentrations of less than 8 µM, induces cell death with characteristics of apoptosis in human prostate cancer cell lines. This effect of ß-lapachone was also observed in a human promyelocytic leukemia cell line (HL-60). ß-Lapachone-induced apoptosis is independent of p53 expression, and ectopic overexpression of bcl-2 did not confer significant resistance to ß-lapachone. Among other human carcinoma and adenoma cell lines tested, human breast and ovary carcinoma showed sensitivity to the cytotoxic effect of ß-lapachone without manifesting signs of apoptosis. These results suggest that ß-lapachone is a potential compound to be added to cancer chemotherapy, particularly for prostate cancer.

1 This work was supported by NIH Grant AI-35511.

2 To whom requests for reprints should be addressed, at Division of Cell Growth and Regulation, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115.

Received 6/14/95. Accepted 7/21/95.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
H. J. Park, E. K. Choi, J. Choi, K.-J. Ahn, E. J. Kim, I.-M. Ji, Y. H. Kook, S.-D. Ahn, B. Williams, R. Griffin, et al.
Heat-Induced Up-Regulation of NAD(P)H:Quinone Oxidoreductase Potentiates Anticancer Effects of {beta}-Lapachone
Clin. Cancer Res., December 15, 2005; 11(24): 8866 - 8871.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
J. A. Olalde Rangel, M. Magarici, F. Amendola, and O. del Castillo
The Systemic Theory of Living Systems. Part IV: Systemic Medicine--The Praxis
Evid. Based Complement. Altern. Med., December 1, 2005; 2(4): 429 - 439.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. B. Pardee
Regulation, Restriction, and Reminiscences
J. Biol. Chem., July 19, 2002; 277(30): 26709 - 26716.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M.-J. Don, Y.-H. Chang, K.-K. Chen, L.-K. Ho, and Y.-P. Chau
Induction of CDK Inhibitors (p21WAF1 and p27Kip1) and Bak in the {beta}-Lapachone-Induced Apoptosis of Human Prostate Cancer Cells
Mol. Pharmacol., April 1, 2001; 59(4): 784 - 794.
[Abstract] [Full Text]


Home page
The OncologistHome page
D. R.A. Mans, A. B. da Rocha, and G. Schwartsmann
Anti-Cancer Drug Discovery and Development in Brazil: Targeted Plant Collection as a Rational Strategy to Acquire Candidate Anti-Cancer Compounds
Oncologist, June 1, 2000; 5(3): 185 - 198.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Li, Y.-Z. Li, A. V. Pinto, and A. B. Pardee
Potent inhibition of tumor survival in vivo by beta -lapachone plus taxol: Combining drugs imposes different artificial checkpoints
PNAS, November 9, 1999; 96(23): 13369 - 13374.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S.-G. Shiah, S.-E. Chuang, Y.-P. Chau, S.-C. Shen, and M.-L. Kuo
Activation of c-Jun NH2-terminal Kinase and Subsequent CPP32/Yama during Topoisomerase Inhibitor {beta}-Lapachone-induced Apoptosis through an Oxidation-dependent Pathway
Cancer Res., January 1, 1999; 59(2): 391 - 398.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. J. Campbell, S. Park, M. R. Uskokovic, M. I. Dawson, and H. P. Koeffler
Expression of Retinoic Acid Receptor-{beta} Sensitizes Prostate Cancer Cells to Growth Inhibition Mediated by Combinations of Retinoids and a 19-nor Hexafluoride Vitamin D3 Analog
Endocrinology, April 1, 1998; 139(4): 1972 - 1980.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Tagliarino, J. J. Pink, G. R. Dubyak, A.-L. Nieminen, and D. A. Boothman
Calcium Is a Key Signaling Molecule in beta -Lapachone-mediated Cell Death
J. Biol. Chem., May 25, 2001; 276(22): 19150 - 19159.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.